Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Fisher

Showing results (41-50 of 84) with videos related to

Pageof 9
Sort By:
International Journal of Radiation Oncology, Biology, Physics|June 14, 2002
Measurement of lung tumor volumes using three-dimensional computer planning softwarePatrick Bowden, Richard Fisher, Michael Mac Manus, et al.
International Journal of Radiation Oncology, Biology, Physics|May 23, 2016
Effect of p16 Status on the Quality-of-Life Experience During Chemoradiation for Locally Advanced Oropharyngeal Cancer: A Substudy of Randomized Trial Trans-Tasman Radiation Oncology Group (TROG) 02.02 (HeadSTART)Jolie Ringash, Richard Fisher, Lester Peters, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 26, 2019
GAIM fusions are therapeutic candidates for peripheral amyloidosisMing Proschitsky, Jonathan Levenson, Michal Lulu, et al.
Journal of Critical Care|January 10, 2021
Provision of acute renal replacement therapy, using three separate modalities, in critically ill patients during the COVID-19 pandemic. An after action review from a UK tertiary critical care centreRichard Fisher, Jonathan Clarke, Khaled Al-Arfi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02Lester J Peters, Brian O'Sullivan, Jordi Giralt, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Stage is not a reliable indicator of tumor volume in non-small cell lung cancer: a preliminary analysis of the Trans-Tasman Radiation Oncology Group 99-05 databaseDavid L Ball, Richard Fisher, Bryan Burmeister, et al.
The American Journal of Medicine|March 15, 2002
Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin's disease and non-Hodgkin's lymphomaAndrew Wirth, John F Seymour, Rodney J Hicks, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 7, 2011
Relationship between epidermal growth factor receptor status, p16(INK4A), and outcome in head and neck squamous cell carcinomaRichard J Young, Danny Rischin, Richard Fisher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2004
Tirapazamine, Cisplatin, and Radiation versus Fluorouracil, Cisplatin, and Radiation in patients with locally advanced head and neck cancer: a randomized phase II trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02)Danny Rischin, Lester Peters, Richard Fisher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 6, 2018
Randomized Trial of Systemic Therapy After Involved-Field Radiotherapy in Patients With Early-Stage Follicular Lymphoma: TROG 99.03Michael MacManus, Richard Fisher, Daniel Roos, et al.
Pageof 9

Showing results (41-50 of 84) with videos related to

Sort By:
Pageof 9
International Journal of Radiation Oncology, Biology, Physics|June 14, 2002
Measurement of lung tumor volumes using three-dimensional computer planning softwarePatrick Bowden, Richard Fisher, Michael Mac Manus, et al.
International Journal of Radiation Oncology, Biology, Physics|May 23, 2016
Effect of p16 Status on the Quality-of-Life Experience During Chemoradiation for Locally Advanced Oropharyngeal Cancer: A Substudy of Randomized Trial Trans-Tasman Radiation Oncology Group (TROG) 02.02 (HeadSTART)Jolie Ringash, Richard Fisher, Lester Peters, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 26, 2019
GAIM fusions are therapeutic candidates for peripheral amyloidosisMing Proschitsky, Jonathan Levenson, Michal Lulu, et al.
Journal of Critical Care|January 10, 2021
Provision of acute renal replacement therapy, using three separate modalities, in critically ill patients during the COVID-19 pandemic. An after action review from a UK tertiary critical care centreRichard Fisher, Jonathan Clarke, Khaled Al-Arfi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02Lester J Peters, Brian O'Sullivan, Jordi Giralt, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Stage is not a reliable indicator of tumor volume in non-small cell lung cancer: a preliminary analysis of the Trans-Tasman Radiation Oncology Group 99-05 databaseDavid L Ball, Richard Fisher, Bryan Burmeister, et al.
The American Journal of Medicine|March 15, 2002
Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin's disease and non-Hodgkin's lymphomaAndrew Wirth, John F Seymour, Rodney J Hicks, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 7, 2011
Relationship between epidermal growth factor receptor status, p16(INK4A), and outcome in head and neck squamous cell carcinomaRichard J Young, Danny Rischin, Richard Fisher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2004
Tirapazamine, Cisplatin, and Radiation versus Fluorouracil, Cisplatin, and Radiation in patients with locally advanced head and neck cancer: a randomized phase II trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02)Danny Rischin, Lester Peters, Richard Fisher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 6, 2018
Randomized Trial of Systemic Therapy After Involved-Field Radiotherapy in Patients With Early-Stage Follicular Lymphoma: TROG 99.03Michael MacManus, Richard Fisher, Daniel Roos, et al.
Pageof 9